Fate Therapeutics (FATE) EPS (Basic) (2012 - 2026)
Fate Therapeutics' (FATE) quarterly EPS (Basic) came in at -$1.23 in Q1 2026, up 13.22% YoY from -$1.09 in Q1 2025, and down 349.8% on a QoQ basis from -$0.27 in Q4 2025.
Powered by 
Analysis
Fate Therapeutics (FATE) EPS (Basic) (2012 - 2026) Analysis & Trends
Fate Therapeutics (FATE) has 15 years of EPS (Basic) data on file, last reported at -$1.23 in Q1 2026.
- Quarterly EPS (Basic) rose 13.22% year-over-year to -$1.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 (up 69.87% YoY) and the FY2025 annual result came in at -$4.42, up 9.54% from the prior year.
- EPS (Basic) fell to -$1.23 in Q1 2026, from -$0.27 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.27 in Q4 2025 to a low of -$3.74 in Q4 2023.
- A 5-year average of -$1.71 and a median of -$1.42 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) slumped 105.16% — and 2025, when it jumped 92.59%.
- Tracing FATE's EPS (Basic) over 5 years: stood at -$3.7 in 2022, then dropped by 1.09% to -$3.74 in 2023, then grew by 1.11% to -$3.69 in 2024, then jumped by 92.59% to -$0.27 in 2025, then sank by 349.8% to -$1.23 in 2026.
- The last three EPS (Basic) figures came in at -$1.23 (Q1 2026), -$0.27 (Q4 2025), and -$0.63 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Fate Therapeutics | 299.79 Mn | 299.79 Mn | - | -0.25 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.25 |
| Mar 31, 2026 | -0.26 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | -0.29 |
| Mar 31, 2025 | -0.32 |
| Dec 31, 2024 | -0.51 |
| Sep 30, 2024 | -0.41 |
| Jun 30, 2024 | -0.34 |
| Mar 31, 2024 | -0.46 |
| Dec 31, 2023 | -0.44 |
| Sep 30, 2023 | -0.47 |
| Jun 30, 2023 | -0.59 |
| Mar 31, 2023 | -0.25 |
| Dec 31, 2022 | -0.64 |
| Sep 30, 2022 | -0.87 |
| Jun 30, 2022 | -0.85 |
| Mar 31, 2022 | -0.77 |
| Dec 31, 2021 | -0.73 |
| Sep 30, 2021 | -0.57 |